Cited by 207Microbial Metabolites in Food BiotechnologyAdipokines, Inflammation, and Metabolic DiseasesNatural Antidiabetic Agents Studies

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial

Dehghan, Parvin, Pourghassem Gargari, Bahram, Asghari Jafar-abadi, Mohammad·2014·Nutrition

DOI 10.1016/j.nut.2013.09.005

Open this paper in CoChat — free account

Abstract

Objectives Anti-inflammatory therapeutic approaches are considered for the management of type 2 diabetes and for the prevention of its complications. There is limited evidence regarding the effects of prebiotics on inflammation, especially in patients with type 2 diabetes. This trial aims to examine the effects of oligofructose-enriched inulin on glycemic status, inflammation markers, and metabolic endotoxemia in female patients.Methods Over a period of 8 wk, 52 women with body mass indices of >25 kg/m(2) but <35 kg/m(2) with type 2 diabetes were randomly assigned to either an intervention group, in which participants were given oligofructose-enriched inulin (n = 27, consuming 10 g/d of oligofructose-enriched inulin), or to a control group, in which participants were given maltodextrin (n = 25, consuming 10 g/d of maltodextrin). Fasting plasma glucose, glycosylated hemoglobin, high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-α, interferon-γ, interleukin-10, and plasma lipopolysaccharide were measured before and after the intervention. Data were analyzed with the use of SPSS software version 13. Paired and unpaired Student t tests and analysis of covariance were used to compare quantitative variables.Results Oligofructose-enriched inulin caused a significant decrease in the levels of fasting plasma glucose (19.2 mg/dL; 9.50%), glycosylated hemoglobin (1.0%; 8.40%), interleukin-6 (1.3 pg/mL; 8.15%), tumor necrosis factor-α (3.0 pg/mL; 19.80%) and plasma lipopolysaccharide (6.0 EU/mL; 21.95%) as compared with maltodextrin (P < 0.05). Decreases in levels of interferon-γ (0.3 pg/mL; 16.50%) and high-sensitivity C-reactive protein (3.9 ng/mL; 31.70%) and an increase in the level of interleukin-10 (0.4 pg/mL, 11.50%) were not significant in the oligofructose-enriched inulin group as compared with the maltodextrin group.Conclusions In women with type 2 diabetes and suboptimal daily dietary fiber intake, oligofructose-enriched inulin may help to modulate some inflammatory markers.

Integrity signals

Registry

Crossref · 10.1016/j.nut.2013.09.005

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,094
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,918
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia
Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,770
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s5 · Cited by 1,690
Clinical trials: A practical approach
Daly, M. J. (1984) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(84)90515-7 · Cited by 1,057
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes
Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., & Kumar, S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2006 · Cited by 1,043
The role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974
Inulin-Type Fructans: Functional Food Ingredients
Roberfroid, M. B. (2007) · Journal of Nutrition · doi:10.1093/jn/137.11.2493s · Cited by 895
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women
Dewulf, E. M., Cani, P. D., Claus, S. P., Fuentes, S., Puylaert, P. G., Neyrinck, A. M., Bindels, L. B., de Vos, W. M., Gibson, G. R., Thissen, J.-P., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303304 · Cited by 825
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Parnell, J. A., & Reimer, R. A. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27465 · Cited by 749
Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications
Goldberg, R. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2534 · Cited by 650
Hyperglycemia-induced oxidative stress in diabetic complications
King, G. L., & Loeken, M. R. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0678-9 · Cited by 497
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Volti, G. L., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 459
Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor
Cani, P. D., Knauf, C., Iglesias, M. A., Drucker, D. J., Delzenne, N. M., & Burcelin, R. (2006) · Diabetes · doi:10.2337/db05-1360 · Cited by 420
Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel
Langlands, S. J. (2004) · Gut · doi:10.1136/gut.2003.037580 · Cited by 361
Including Indigestible Carbohydrates in the Evening Meal of Healthy Subjects Improves Glucose Tolerance, Lowers Inflammatory Markers, and Increases Satiety after a Subsequent Standardized Breakfast
Nilsson, A. C., Östman, E. M., Holst, J. J., & Björck, I. (2008) · Journal of Nutrition · doi:10.1093/jn/138.4.732 · Cited by 302
Prebiotic Capacity of Inulin-Type Fructans
Kolida, S., & Gibson, G. R. (2007) · Journal of Nutrition · doi:10.1093/jn/137.11.2503s · Cited by 281
Effects of fructo-oligosaccharides on blood glucose and serum lipids in diabetic subjects
Yamashita, K., Kawai, K., & Itakura, M. (1984) · Nutrition Research · doi:10.1016/s0271-5317(84)80075-5 · Cited by 272
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
Burcelin, R., Sérino, M., Chabo, C., Blasco‐Baqué, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 270
Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties
Lecerf, J.-M., Dépeint, F., Clerc, E., Dugenet, Y., Niamba, C. N., Rhazi, L., Cayzeele, A., Abdelnour, G., Jaruga, A., Younes, H., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511007252 · Cited by 262
Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism
Caesar, R., Fåk, F., & Bäckhed, F. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02270.x · Cited by 254
Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation
Suganami, T., Mieda, T., Itoh, M., Shimoda, Y., Kamei, Y., & Ogawa, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.190 · Cited by 230
Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial
Jain, P. K., McNaught, C. E., Anderson, A. D. G., Macfie, J., & Mitchell, C. J. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2003.12.002 · Cited by 211
Innate immunity, insulin resistance and type 2 diabetes
Fernández‐Real, J. M., & Pickup, J. C. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.10.004 · Cited by 206
Randomised clinical trial of synbiotic therapy in elective surgical patients
Anderson, A. D. G., McNaught, C. E., Jain, P. K., & MacFie, J. (2004) · Gut · doi:10.1136/gut.2003.024620 · Cited by 199
HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα
Place, R. F., Noonan, E. J., & Giardina, C. A. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.030 · Cited by 189
Effects of High Performance Inulin Supplementation on Glycemic Control and Antioxidant Status in Women with Type 2 Diabetes
Gargari, B. P., Dehghan, P., Aliasgharzadeh, A., & Jafarabadi, M. A. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.2.140 · Cited by 179
Self-citation
Prebiotic Oligosaccharides Reduce Proinflammatory Cytokines in Intestinal Caco-2 Cells via Activation of PPARγ and Peptidoglycan Recognition Protein 31–3
Zenhom, M., Hyder, A., de Vrese, M., Heller, K. J., Roeder, T., & Schrezenmeir, J. (2011) · Journal of Nutrition · doi:10.3945/jn.110.136176 · Cited by 174
Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract
Cherbut, C. (2003) · Proceedings of The Nutrition Society · doi:10.1079/pns2002213 · Cited by 166
Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes
Alles, M. S., de Roos, N. M., Bakx, J. C., Lisdonk, E. H. V. D., Zock, P. L., & HAUTVAST, J. G. A. J. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.64 · Cited by 163
Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men
Sharman, M. J., & Volek, J. S. (2004) · Clinical Science · doi:10.1042/cs20040111 · Cited by 143
Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NFκB signalling
Schwab, M., Reynders, V., Loitsch, S. M., Steinhilber, D., Stein, J. M., & Schröder, O. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.04.010 · Cited by 133
Butyrate Switches the Pattern of Chemokine Secretion by Intestinal Epithelial Cells through Histone Acetylation
Fusunyan, R. D., Quinn, J. J., Fujimoto, M., MacDermott, R. P., & Sanderson, I. R. (1999) · Molecular Medicine · doi:10.1007/bf03402075 · Cited by 117
Can dietary fructans lower serum glucose?
Bonsu, N. K. A., Johnson, S., & McLeod, K. M. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00099.x · Cited by 64
Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia
Andreasen, A. S., Pedersen-Skovsgaard, T., Berg, R. M. G., Svendsen, K. D., Feldt‐Rasmussen, B., Pedersen, B. K., & Møller, K. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1845-1 · Cited by 61
Different Effects of Short- and Long-Chained Fructans on Large Intestinal Physiology and Carcinogen-Induced Aberrant Crypt Foci in Rats
Poulsen, M., Mølck, A., & Jacobsen, B. L. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc422_8 · Cited by 59
Supplemental Dietary Inulin Influences Expression of Iron and Inflammation Related Genes in Young Pigs
Yasuda, K., Dawson, H. D., Wasmuth, E. V., Roneker, C. A., Chen, C. Y., Urban, J. F., Welch, R. M., Miller, D. D., & Lei, X. G. (2009) · Journal of Nutrition · doi:10.3945/jn.109.110528 · Cited by 52
Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets
Pouillart, P., Dépeint, F., Nour, A. M. A., Deremaux, L., Vincent, O., Mazière, J., Madec, J.-Y., Chatelain, D., Younes, H., Wils, D., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21130 · Cited by 36
Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?
Knaapen, M., Kootte, R. S., Zoetendal, E. G., de Vos, W. M., Dallinga‐Thie, G. M., Levi, M. M., Stroes, E. S. G., & Nieuwdorp, M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12170 · Cited by 26
Mechanisms of acute hyperinsulinemia after Kupffer cell phagocytosis
Cornell, R. P. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.3.e276 · Cited by 16

Sorted by citations

The gut microbiota at the intersection of diet and human health
Gentile, C. L., & Weir, T. L. (2018) · Science · doi:10.1126/science.aau5812 · Cited by 1,049
Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity
Nicolucci, A. C., Hume, M. P., Martínez, I., Mayengbam, S., Walter, J., & Reimer, R. A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.055 · Cited by 529
The Intestinal Immune System in Obesity and Insulin Resistance
Winer, D. A., Luck, H., Tsai, S. J., & Winer, S. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.003 · Cited by 493
Metabolic endotoxemia with obesity: Is it real and is it relevant?
Boutagy, N. E., McMillan, R. P., Frisard, M. I., & Hulver, M. W. (2016) · Biochimie · doi:10.1016/j.biochi.2015.06.020 · Cited by 413
The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity
Cerdó, T., García-Santos, J. A., García-Bermúdez, M., & Campoy, C. (2019) · Nutrients · doi:10.3390/nu11030635 · Cited by 439

See all 207

Authors: Dehghan, P., Pourghassem Gargari, B., & Asghari Jafar-abadi, M.
Affiliations: Tabriz University of Medical Sciences (IR)
ORCID: Dehghan, Parvin
Venue: Nutrition
Publisher: Elsevier BV
Published: 2014-04
Volume: 30
Issue: 4
Pages: 418-423
ISSN: 0899-9007 (ISSN-L)
DOI: 10.1016/j.nut.2013.09.005
OpenAlex: W1977968392
Cited by: 207
References: 43
Citations by year: 2026: 5 · 2025: 22 · 2024: 18 · 2023: 12 · 2022: 38 · 2021: 13 · 2020: 14 · 2019: 25 · 2018: 12 · 2017: 15 · 2016: 13 · 2015: 15 · 2014: 4
FWCI: 9.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Nutrition (publishedVersion)
PubMed (publishedVersion)
Funders: University of Tabriz
Topics: Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords: oligofructose-enriched inulin, prebiotics, type 2 diabetes, women, inflammatory markers, endotoxemia, lipopolysaccharide, glycemic control, HbA1c, fasting blood glucose, interleukin-6, TNF-α, C-reactive protein, IL-10, interferon-gamma
MeSH terms: Adult, Blood Glucose, C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Inflammation, Interferon-gamma, Inulin, Lipopolysaccharides, Middle Aged, Oligosaccharides, Tumor Necrosis Factor-alpha, Biomarkers, Interleukin-6, Body Mass Index, Endotoxemia, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: A randomized controlled clinical trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks